Our method has been demonstrated to be more efficient in capturing NSCLC cells (P < 0.01) by enriching three types of CTCs: EpCAM+/FRα−/low, EpCAM−/low/FRα+, and EPCAM+/FRα+. The gene discussed is FOLR1; the disease is non-small cell lung carcinoma.